Shuxin Li Selected Research

Chondroitin Sulfate Proteoglycans

1/2021	LAR inhibitory peptide promotes recovery of diaphragm function and multiple forms of respiratory neural circuit plasticity after cervical spinal cord injury.
11/2020	Glial Metabolic Rewiring Promotes Axon Regeneration and Functional Recovery in the Central Nervous System.
1/2020	Advances in the Signaling Pathways Downstream of Glial-Scar Axon Growth Inhibitors.
1/2018	RhoA activation in axotomy-induced neuronal death.
9/2015	Molecular mechanisms of scar-sourced axon growth inhibitors.
1/2015	Role of CSPG receptor LAR phosphatase in restricting axon regeneration after CNS injury.
10/2012	Scar-mediated inhibition and CSPG receptors in the CNS.
2/2007	Functional axonal regeneration through astrocytic scar genetically modified to digest chondroitin sulfate proteoglycans.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Shuxin Li Research Topics

Disease

14	Wounds and Injuries (Trauma) 01/2021 - 05/2003
12	Spinal Cord Injuries (Spinal Cord Injury) 01/2021 - 05/2003
5	Infections 05/2022 - 01/2021
5	Cicatrix (Scar) 11/2020 - 02/2007
5	Neoplasms (Cancer) 10/2020 - 08/2012
4	Inflammation (Inflammations) 12/2020 - 01/2004
3	Gliosis 01/2020 - 02/2015
3	Pain (Aches) 10/2011 - 04/2007
3	Fever (Fevers) 05/2005 - 11/2003
2	Contusions 09/2008 - 04/2007
2	Spinal Injuries (Spinal Injury) 05/2005 - 11/2004
1	Virus Diseases (Viral Diseases) 10/2021
1	Communicable Diseases (Infectious Diseases) 01/2021
1	Pulmonary Fibrosis (Fibrosing Alveolitis) 01/2021
1	Wound Infection (Wound Infections) 01/2021
1	Paralysis (Palsy) 01/2021
1	Idiopathic Pulmonary Fibrosis 01/2021
1	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 12/2020
1	Prostatic Neoplasms (Prostate Cancer) 10/2020
1	Traumatic Brain Injuries (Traumatic Brain Injury) 01/2020
1	Surgical Wound 01/2020
1	Myocardial Ischemia (Ischemic Heart Diseases) 12/2018
1	Osteoarthritis 01/2018
1	Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental) 10/2017
1	Encephalomyelitis (Myeloencephalitis) 10/2017
1	Nervous System Diseases (Neurological Disorders) 09/2015

Drug/Important Bio-Agent (IBA)

8	Chondroitin Sulfate ProteoglycansIBA 01/2021 - 02/2007
6	Peptides (Polypeptides)IBA 01/2021 - 10/2011
4	Prostaglandin-Endoperoxide Synthases (Cyclooxygenase)IBA 10/2011 - 11/2003
3	Growth InhibitorsIBA 01/2020 - 09/2015
3	Ibuprofen (Motrin)FDA LinkGeneric 10/2011 - 04/2007
3	Nogo Receptor 1IBA 05/2005 - 05/2003
3	ProstaglandinsIBA 05/2005 - 11/2003
2	Antiviral Agents (Antivirals)IBA 05/2022 - 01/2022
2	Pharmaceutical PreparationsIBA 12/2020 - 01/2010
2	Proteins (Proteins, Gene)FDA Link 12/2018 - 05/2005
2	EnzymesIBA 09/2015 - 11/2003
2	Proteoglycans (Proteoglycan)IBA 02/2015 - 04/2007
2	Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA 10/2011 - 04/2007
2	Indomethacin (Indometacin)FDA LinkGeneric 10/2011 - 04/2007
2	LipopolysaccharidesIBA 05/2005 - 01/2004
2	CytokinesIBA 05/2005 - 01/2004
2	Dinoprostone (PGE2)FDA Link 05/2005 - 01/2004
2	Complement System Proteins (Complement)IBA 05/2005 - 01/2004
2	InterleukinsIBA 01/2004 - 11/2003
1	DNA Primase (Primase)IBA 05/2022
1	Ammonium Chloride (Sal Ammoniac)FDA Link 01/2022
1	Sucrose (Saccharose)IBA 01/2022
1	bafilomycin A1IBA 01/2022
1	ClathrinIBA 01/2022
1	N'- (3,4- dihydroxybenzylidene)- 3- hydroxy- 2- naphthahydrazideIBA 01/2022
1	Chlorpromazine (Thorazine)FDA Link 01/2022
1	Chloroquine (Aralen)FDA LinkGeneric 01/2022
1	Transcription Factors (Transcription Factor)IBA 10/2021
1	Clioquinol (Vioform)FDA Link 01/2021
1	IronIBA 01/2021
1	InflammasomesIBA 01/2021
1	C-Reactive ProteinIBA 01/2021
1	ProcalcitoninIBA 01/2021
1	Peptide Hydrolases (Proteases)FDA Link 01/2021
1	Biomarkers (Surrogate Marker)IBA 01/2021
1	CaspasesIBA 01/2021
1	leukocyte esteraseIBA 01/2021
1	Cisplatin (Platino)FDA LinkGeneric 12/2020
1	Biotin (Vitamin H)FDA Link 12/2020
1	neutravidinIBA 12/2020
1	ChemokinesIBA 10/2020
1	Hyaluronic Acid (Hyaluronan)IBA 10/2020
1	Matrix Metalloproteinases (MMPs)IBA 01/2020
1	Fluorescent Dyes (Fluorescent Probes)IBA 01/2020
1	poly-N-isopropylacrylamideIBA 01/2020
1	FibrinIBA 01/2020
1	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2020
1	Tissue Adhesives (Tissue Adhesive)IBA 01/2020
1	Class 2 Receptor-Like Protein Tyrosine PhosphatasesIBA 01/2020
1	LigandsIBA 01/2020
1	ChitosanIBA 01/2020
1	Biological ProductsIBA 01/2020
1	Fibrin Tissue Adhesive (Fibrin Sealant)IBA 01/2020
1	hydrogel filmIBA 01/2020
1	hydroxyethyl methacrylate (HEMA)IBA 01/2020
1	Cell Surface ReceptorsIBA 01/2020
1	DisulfidesIBA 12/2018
1	polysulfideIBA 12/2018
1	2-butenal (crotonaldehyde)IBA 12/2018
1	Folic Acid (Vitamin M)FDA LinkGeneric 01/2018
1	Messenger RNA (mRNA)IBA 01/2018
1	IntegrinsIBA 12/2017
1	Collagen Type I (Type I Collagen)IBA 12/2017
1	Cadherins (E-Cadherin)IBA 12/2017
1	Protein Tyrosine PhosphatasesIBA 10/2017
1	Chondroitin ABC LyaseIBA 09/2015
1	TensinsIBA 09/2015
1	Phosphoric Monoester Hydrolases (Phosphatases)IBA 09/2015
1	Small Interfering RNA (siRNA)IBA 09/2015

Therapy/Procedure

7	Therapeutics 01/2021 - 05/2003
3	Injections 10/2020 - 12/2018
1	Axotomy 11/2020
1	Sutures (Suture) 01/2020
1	Transjugular Intrahepatic Portasystemic Shunt 01/2018